pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
BPN-36964
Familial Dysautonomia
Tikun Therapeutics Inc
Preclinical
BPP-1001
Neuroinflammation
Bioscience Pharma Partners LLC
Phase 2
BPZE1 vaccine
Pertussis (Whooping Cough)
ILiAD Biotechnologies LLC
Phase 1
← prev
page 64 of 231
next →
131
Pain
89
Neurology
1
BR-01T
Chronic Low Back Pain (CLBP)
Brise Pharmaceuticals Co Ltd
Phase 2
BRC-OA
Osteoarthritis
Britecyte Inc
Phase 1
BREAD-01
Atopic Dermatitis (Atopic Eczema)
Brexogen Inc
Preclinical
BREN-01
Amyotrophic Lateral Sclerosis
BrainEver SAS
Preclinical
BREN-02
Amyotrophic Lateral Sclerosis
BrainEver SAS
Phase 1
BRII-732
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Brii Biosciences Ltd
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
no indication
REGCON HOLDINGS
Phase 3
BRM-421
Keratoconjunctivitis Sicca (Dry Eye)
BRIM Biotechnology Inc
Phase 2
BRM-424
Neurotrophic Keratitis
BRIM Biotechnology Inc
BROMFENAC OPHTHALMIC SOLUTION 0.09%
BROMFENAC OPHTHALMIC SOLUTION 0.09%
no indication
ALEMBIC
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
no indication
PADAGIS US
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,
no indication
HIBROW HLTHCARE
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE)
no indication
ACELLA
Phase 1
BRS-101
Idiopathic Pulmonary Fibrosis
BreStem Therapeutics Inc
Preclinical
BRST-33
Breast Cancer
$CNBX
CNBX Pharmaceuticals Inc.
Phase 2
BRTX-100
brtxDISC
Chronic Low Back Pain (CLBP)
$BRTX
BioRestorative Therapies, Inc.
Phase 2
BS-001
Melanoma
Wuhan Binhui Biopharmaceutical Co Ltd
Phase 2
BS-01
Retinitis Pigmentosa (Retinitis)
Beacon Therapeutics Ltd
Phase 2
BSI-04702
Solid Tumor
OBI Pharma Inc
Phase 1
BSI-082
Solid Tumor
Biosion Inc
Phase 1
BSI-502
Atopic Dermatitis (Atopic Eczema)
$ACRS
Aclaris Therapeutics, Inc.
BSS
BSS (BALANCED SALT SOLUTION)
no indication
ALCON
Preclinical
BT-1501
Colorectal Cancer
Barricade Therapeutics Corp
Preclinical
BT-63
Type 1 Diabetes (Juvenile Diabetes)
BioTherapeutics Inc
Phase 2
BT-7480
Anal Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
Preclinical
BT-820
Liver Diseases
Base Therapeutics
Phase 2
BTM-3566
Burkitt Lymphoma
Bantam Pharmaceutical LLC
